EN DE
STOCK COMPARISON

Carasent ASA vs Veeva Systems Inc Class A: Fair Value & Quality

Both stocks run through our valuation models. Here is how Carasent ASA (CARA) and Veeva Systems Inc Class A (VEEV) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Veeva Systems Inc Class A as the less overvalued of the two: Carasent ASA trades at SEK 25.90 versus a fair value of SEK 8.82 (-66%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).
Carasent ASA
CARA.ST · SEK · Health Care
-66%
upside to fair value
overvalued
PriceSEK 25.90
Fair ValueSEK 8.82
Quality66/100
Veeva Systems Inc Class A
VEEV · USD · Health Care
-59%
upside to fair value
overvalued
Price$230
Fair Value$95.12
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Carasent ASAVeeva Systems Inc Class A
Valuation
39.4×P/E (TTM)33.6×
4.48×P/S (TTM)9.31×
2.02×P/B4.28×
55.8×EV/EBITDA28.7×
PEG0.85×
Profitability
12%Net margin28%
-3%Operating margin31%
5%Return on equity14%
1%Return on assets7%
Growth
18%Revenue growth (YoY)16%
20.8%Avg. growth/yr (3Y)14.0%
37.3%Avg. growth/yr (5Y)16.9%
Balance & size
$172MMarket cap$31B
mixedGrowth qualityhealthy

Veeva Systems Inc Class A leads: 5 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Carasent ASAof which business quality 64 · market factors 49 Veeva Systems Inc Class Aof which business quality 72 · market factors 48
ProfitabilityMargins and returns on capital today
37
57
Quality GrowthAre margins and returns improving?
89
65
CashflowEarnings quality: real cash, not paper profit
27
93
Fin. StrengthBalance sheet, leverage, solvency risk
76
91
InvestmentDisciplined investing over empire-building
82
33
Low VolatilityCalm price path (market factor)
82
55
MomentumPrice trend over the last 3–12 months (market factor)
36
52
52W MomentumDistance to the 52-week high (market factor)
35
31
Net IssuanceBuybacks instead of dilution
100
72

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Carasent ASA

DCF ModelsSEK 19.20
Earnings-BasedSEK 10.06
MultiplesSEK 8.82
Asset-BasedSEK 8.10
Economic ProfitSEK 5.77
Growth EarningsSEK 14.18

15 of 15 models see the stock below the current price.

Veeva Systems Inc Class A

DCF Models$214
Earnings-Based$142
Dividend Discount$0.41
Multiples$93.60
Asset-Based$29.76
Growth DCF$200
Economic Profit$57.47
Growth Earnings$185

21 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Carasent ASA
Bear SEK 6.61Fair Value SEK 8.82Bull SEK 11.02
SEK 25.90 = current price (white tick)
Veeva Systems Inc Class A
Bear $71.34Fair Value $95.12Bull $146
$230 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Carasent ASA · Health Care

Quality score66 · Top 25%
Fair value upside-66% · bottom 25%

Veeva Systems Inc Class A · Health Care

Quality score72 · Top 25%
Fair value upside-59% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Veeva Systems Inc Class A as the less overvalued of the two: Carasent ASA trades at SEK 25.90 versus a fair value of SEK 8.82 (-66%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).

Veeva Systems Inc Class A has the higher quality score (72/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.